For decades, U.S. health care costs have soared while over one-third of Americans can’t afford quality medical care. But what if we’re misdiagnosing the problem entirely?
Health care accounts for 18 percent of U.S. GDP ($4.9 trillion)—making it the world’s third-largest economy if it were a country. Yet the U.S. ranks last among 11 high-income nations in access, equity, and outcomes despite spending twice per capita compared to peers.
Experts invariably blame aging populations (65+ increasing 47 percent by 2050), disease burden (42.4 percent adult obesity driving $301 billion in specialty drug spending), workforce crisis leading to delayed care (124,000 physician shortage by 2034), and price distortions (private insurers paying 254 percent of Medicare rates).
These explanations drive misdirected reforms—the ACA, $27 billion in EHR investments, surprise billing acts—addressing symptoms while leaving systemic dysfunction intact.
Enter: The hidden architect of dysfunction.
The three fundamental problems
Health care’s true villain isn’t any broken component—it’s the absence of accountability for total health outcomes. Evidence: 60 percent of AI health care investment since 2021 has gone to administrative functions rather than health improvement. We’re using our most powerful technology to optimize paperwork in a fundamentally broken system.
This reveals three critical problems:
1. No quarterback accountable for total health outcomes.
This is the root cause. Most health insurance coverage lasts only three to four years on average, based on median employee tenure. No single entity has financial incentive to invest in long-term health outcomes when patients will likely be someone else’s responsibility tomorrow.
The result: a “sick-care” system. Cancer patients diagnosed early cost two to four times less than advanced cases, yet we excel at expensive acute interventions while failing at prevention. The top 5 percent of patients consume 75 percent of hospital inpatient expenses—much preventable, with one in seven admissions are preventable through better care pathways. Preventable hospitalizations cost $33.7 billion in 2017 alone.
We spend only 2.9 percent on prevention (down from 3.7 percent in 2000) while countries investing 6 percent to 8 percent achieve 3.6 years longer life expectancy, despite spending less overall.
Contrast: Medicare Advantage demonstrates what’s possible with accountability—only 11 percent switch plans annually versus 25 percent to 33 percent implied by employer coverage tenure. This stability enables prevention investment exactly missing in employer-based systems. This accountability advantage is validated by research. Recent large-scale analysis of 17 physician groups shows Medicare Advantage beneficiaries under two-sided risk contracts had superior quality and efficiency outcomes compared to fee-for-service arrangements within the same physician groups. This demonstrates that financial risk for total health outcomes drives better care delivery.
2. Value-blind pricing
JAMA estimates $230 to $240 billion in annual “pricing failure” waste—the largest waste category. U.S. drug prices are 2.78 times higher than 33 OECD countries, spending $1,126 per capita versus $552 average.
Unlike other nations that negotiate prices based on clinical value, the U.S. allows “what the market will bear” pricing. Private insurers pay hospitals 254 percent of Medicare rates, creating chaos where identical services cost wildly different amounts based on market power, not outcomes.
3. Byzantine administrative waste
Administrative complexity wastes $315 to $630 billion annually. The U.S. spends $1,055 per capita on administration versus Germany’s $306—over 3x higher. Physicians spend more time on administrative tasks than patient care, navigating hundreds of insurance plans with different prior authorization requirements.
Electronic health records became digital paperwork mills, forcing dozens of clicks to document simple visits.
These three fundamental problems demand market-driven solutions that address the root cause—lack of accountability for total health outcomes.
A new path forward
Five market-driven approaches can confront health care’s hidden villain:
1. Incentive alignment for Total Health
Policy and free market innovations can incentive total health. Some examples include: Create 15 percent to 25 percent provider bonuses for superior health outcomes. Implement tax deductions for prevention investments (modeled after R&D credits). Establish consumer health credit systems—$500 HSA credits for wellness programs, 25 percent co-pay reductions for meeting clinical targets. Enable cross-sector risk pools where prevention savings accrue to original investors over five to seven years.
2. Payor transformation
Direct Employer Innovation: Consider primary care partnerships to serve as front door easy access that drive right patient, right site of care, at right time and eliminate fee-for-service incentives that drive over-utilization.
Implement Centers of Excellence programs with transparent, bundled pricing—guaranteed costs for major procedures like joint replacements, cardiac surgery and cancer care with savings shared between employers and providers.
Launch transparent pharmacy benefit models that eliminate traditional PBM rebate schemes, publishing actual drug costs and charging transparent administration fees. Create employer-health system partnerships where companies co-invest in prevention infrastructure—workplace health centers, chronic disease management programs and mental health services—with shared financial risk arrangements that reward population health improvements over three to five year periods.
3. Health system transformation
Generate 40 percent to50 percent revenue from value-based contracts and prevention services. Create joint ventures with employers and communities for population health delivery. Build integrated health campuses combining primary care, fitness, nutrition and social services. Take full financial risk for populations with multiyear outcome guarantees.
4. Information Transparency
Mandate consumer-friendly comparisons: “Diabetes care: Provider A $32K/85 percent success vs. Provider B $45K/60 percent success.” Deploy AI-powered health navigation apps showing total episode costs and expected outcomes. Require annual community health impact reports from all major systems and insurers.
5. Technology-enabled Disruption
Implement patient-owned health data standards with automatic penalties for blocking. Deploy AI-powered prior authorization, eliminating $20 billion in unnecessary appeals. Use predictive analytics, identifying high-risk patients 12 to18 months before costly episodes. Create precision prevention platforms using machine learning for personalized interventions.
The Bottom line
Until the industry addresses the systematic absence of incentives for total health—health care’s real Keyser Söze—even our most innovative technologies will optimize a broken system.
The encouraging news: transformation pieces are emerging. Value-based care contracts represent over $100 billion annually, employer coalitions demonstrate cost reduction innovations and early AI implementations support rather than just process health care.
The question isn’t whether change will come, but whether stakeholders will recognize the true problem before more resources fight symptoms instead of causes. We don’t need more tools—we need different incentives at scale.
For health systems, continuing a volume-based focus may prove disadvantageous as payment models evolve. Those who build for total health—not just treat illness—will thrive in the next era. But only if they first name the real villain.
The opinions expressed here by Inc.com columnists are their own, not those of Inc.com.
The early-rate deadline for the 2026 Inc. Regionals Awards is Friday, November 14, at 11:59 p.m. PT. Apply now.
Dr. Feby Abraham
Source link